ImmunoGen Inc (NASDAQ:IMGN)

8.52
Delayed Data
As of Mar 30
 +0.27 / +3.27%
Today’s Change
5.34
Today|||52-Week Range
15.59
+39.67%
Year-to-Date

Today’s Trading

Previous close8.25
Today’s open8.31
Day’s range-- - --
Volume1,840,495
Average volume (3 months)1,594,049
Market cap$710.4M
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+21.58%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book9.36

Competitors

 Today’s
change
Today’s
% change
ANIPANI Pharmaceuticals ...+0.99+1.60%
RTRXRetrophin Inc+2.29+10.47%
AERIAerie Pharmaceutical...+0.38+1.23%
AEGRAegerion Pharmaceuti...-0.13-0.50%
Data as of 03/30/2015

Financials

Next reporting dateApril 24, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account